ES2546766T3 - Cenizas de las cascarillas de café una vez han sido tostadas y separadas del núcleo del café para uso como medicamento tópico - Google Patents

Cenizas de las cascarillas de café una vez han sido tostadas y separadas del núcleo del café para uso como medicamento tópico Download PDF

Info

Publication number
ES2546766T3
ES2546766T3 ES11718761.7T ES11718761T ES2546766T3 ES 2546766 T3 ES2546766 T3 ES 2546766T3 ES 11718761 T ES11718761 T ES 11718761T ES 2546766 T3 ES2546766 T3 ES 2546766T3
Authority
ES
Spain
Prior art keywords
coffee
roasted
once
separated
core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11718761.7T
Other languages
English (en)
Inventor
Feliu PONT GONZÁLEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2546766T3 publication Critical patent/ES2546766T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cenizas de las cascarillas de café una vez han sido tostadas y separadas del núcleo del café para uso como medicamento tópico. Cenizas de las cascarillas de café una vez han sido tostadas y separadas del núcleo del café para uso en el tratamiento de enfermedades de la piel.

Description

imagen1
imagen2

Claims (1)

  1. imagen1
ES11718761.7T 2010-02-26 2011-02-25 Cenizas de las cascarillas de café una vez han sido tostadas y separadas del núcleo del café para uso como medicamento tópico Active ES2546766T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES201030290 2010-02-26
ES201030290A ES2364633B1 (es) 2010-02-26 2010-02-26 Uso de las cenizas de las cascarillas del cafe tostado como tratamiento contra la psoriasis.
PCT/ES2011/070126 WO2011104415A2 (es) 2010-02-26 2011-02-25 Cenizas de las cascarillas de café una vez han sido tostadas y separadas del núcleo del café para uso como medicamento tópico

Publications (1)

Publication Number Publication Date
ES2546766T3 true ES2546766T3 (es) 2015-09-28

Family

ID=44243129

Family Applications (2)

Application Number Title Priority Date Filing Date
ES201030290A Expired - Fee Related ES2364633B1 (es) 2010-02-26 2010-02-26 Uso de las cenizas de las cascarillas del cafe tostado como tratamiento contra la psoriasis.
ES11718761.7T Active ES2546766T3 (es) 2010-02-26 2011-02-25 Cenizas de las cascarillas de café una vez han sido tostadas y separadas del núcleo del café para uso como medicamento tópico

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES201030290A Expired - Fee Related ES2364633B1 (es) 2010-02-26 2010-02-26 Uso de las cenizas de las cascarillas del cafe tostado como tratamiento contra la psoriasis.

Country Status (3)

Country Link
EP (1) EP2540280B1 (es)
ES (2) ES2364633B1 (es)
WO (1) WO2011104415A2 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB190920089A (en) * 1909-09-02 1910-09-02 Robert Macpherson Improvements in Soap and the Manufacture thereof.
CA1077836A (en) * 1977-06-22 1980-05-20 Ellias, Markitta N. Therapeutical composition for the treatment of dermatoses
BE903646A (fr) * 1985-11-14 1986-05-14 Huysmans Guy A Composition pour le traitement et l'entretien de la peau
US5955057A (en) * 1998-06-12 1999-09-21 Biotech Holdings Ltd. Effervescing or foaming bath shape or solid
WO2003000810A1 (en) * 2001-06-25 2003-01-03 Raman Boards Ltd An improved impregnating / coating composition and a composite incorporating the composition
DK1753387T3 (da) * 2004-04-08 2012-09-10 Vdf Futureceuticals Inc Kosmetiske sammensætninger af kaffebær og fremgangsmåder
US20090142412A1 (en) * 2007-12-03 2009-06-04 Giovanna Minutolo Cicillini Skin Care Cosmetic Cream/Scrub Product

Also Published As

Publication number Publication date
ES2364633A1 (es) 2011-09-08
WO2011104415A3 (es) 2011-12-01
WO2011104415A2 (es) 2011-09-01
ES2364633B1 (es) 2012-08-07
EP2540280B1 (en) 2015-06-10
EP2540280A2 (en) 2013-01-02

Similar Documents

Publication Publication Date Title
JP2014141525A5 (es)
BR112014002718A2 (pt) célula, população de célula, composição farmacêutica e kit para uso no tratamento de uma doença de degeneraçãoretinal
USD752233S1 (en) Postpartum abdominal support
EP3052476A4 (en) Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
MX2021000715A (es) Composiciones y metodos para tratar trastornos metabolicos.
IL232256A0 (en) Purine derivatives and their use in the treatment of diseases
IL230957B (en) Pharmacy methods and preparations for the treatment of an eye disease in a patient
ES2446643R1 (es) Composiciones farmacéuticas combinadas y su uso para preparar un medicamento destinado al tratamiento del vértigo, la cinetosis y la distonía vegetativa-vascular
BR112014011981A8 (pt) Formulações farmacêuticas sólidas orais, seus processos de preparação e usos
SG10201704712QA (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
IL245738A0 (en) Oxindole derivatives, ways of their preparation and their therapeutic use in the treatment of ampk-related diseases
WO2014153385A3 (en) Methods of treating metabolic disorders
BR112015029894A2 (pt) forma de dosagem farmacêutica sólida
MX2016014859A (es) Composiciones farmaceuticas que comprenden danirixina para tratar enfermedades infecciosas.
EP3318879A4 (en) Gpc3-targeted therapeutic agent administered to patient in whom gpc3-targetd therapeutic ag
IL231901A0 (en) New compositions of pyrimethanil and their use for crop treatment
EP3326637A4 (en) USE OF MANGOSTINRINDENEXTRACT FOR THE PREPARATION OF MEDICINE FOR THE TREATMENT OF SKIN DISEASES
CL2014001637A1 (es) Preparacion que comprende emodepsido en forma amorfa en una matriz de polivinilpirrolidona; producto farmaceutico que la comprende; y su uso para controlar endoparasitos en seres humanos o animales tales como dirofilaria immitis.
UY31790A (es) Utilización de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia y que tienen un incremento del nivel de creatinina debido a la administración de dronedarona
PT2603238E (pt) Métodos e composições farmacêuticas para o tratamento de uma doença ocular num indíviduo
ES2546766T3 (es) Cenizas de las cascarillas de café una vez han sido tostadas y separadas del núcleo del café para uso como medicamento tópico
WO2014142760A3 (en) Re-trafficking of herg reverses long qt syndrome 2 phenotype in human ips-derived cardiomyocytes
BR112015007610A2 (pt) suplemento alimentar para animais compreendendo ractopamina e cafeína.
ES2656666T3 (es) Alimento para fines médicos especiales o formulación de suplemento alimenticio para tratar trastornos auditivos
GB201410869D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease